Pushing the Envelope in Psychiatric Treatments: Rapid Acting Agents, Psychedelic-Assisted Psychotherapy, and More

Pushing the Envelope in Psychiatric Treatments: Rapid Acting Agents, Psychedelic-Assisted Psychotherapy, and More Banner

Add to Calendar Pushing the Envelope in Psychiatric Treatments: Rapid Acting Agents, Psychedelic-Assisted Psychotherapy, and More 3/21/2020 8:50:00 AM 3/21/2020 4:15:00 PM America/Los_Angeles Online false MM/DD/YYYY


Date & Location
Saturday, March 21, 2020, 8:50 AM - 4:15 PM PST

Overview

We find ourselves at a fascinating time – pushing the envelope on psychiatric treatments, including psychedelic-assisted psychotherapy, rapid-acting agents, and more. As we move forward, this conference emphasizes the need for high-quality research, scientific/empirical evidence, and safeguards against adverse effects and outcomes. Additionally, we need the scholarly efforts of all relevant fields and interprofessional collaborations. This CME activity will cover emerging treatment areas in psychiatry including the related basic science, benefits, risks and clinical trial evidence.


Registration

Registration includes course materials and certificate of participation.

Physician/Clinical Psychologist - $395
Nurse/Allied Health Professional/Other - $345

Register online with Visa or Master Card by visiting stanford.cloud-cme.com/psychiatry.  If you need assistance, please call (650)497-8554 or email stanfordcme@stanford.edu. 

Be sure to register with an email address that you check frequently. Your email address is used for critical information, including registration confirmation, evaluation, and certificate.


Credits
AMA PRA Category 1 Credits™ (6.25 hours), Non-Physician Participation Credit (6.25 hours)

Target Audience
Specialties - Emergency Medicine & Trauma, Family Medicine & Community Health, Internal Medicine, Oncology, Pain Medicine, Psychiatry & Behavioral Sciences


Objectives
At the conclusion of this activity, participants should be able to:

  1. Evaluate emerging therapeutics in psychiatry
  2. Analyze the risk, benefits, and clinical trial evidence relating to emerging therapeutics in psychiatry
  3. Determine the clinical application of emerging therapeutics in psychiatry and consider FDA approved and off label uses

Accreditation
The Stanford University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


Credit Designation
The Stanford University School of Medicine designates this live activity for a maximum of 6.25 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The California Board of Registered Nursing recognizes that Continuing Medical Education (CME) is acceptable for meeting RN continuing education requirements as long as the course is certified for AMA PRA Category 1 CreditsTM (rn.ca.gov).  Nurses will receive a Certificate of Participation following this activity that may be used for license renewal.

Additional Information

Cancellation Policy

Cancellations received in writing no less than 20 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date. Please send cancellation requests to stanfordcme@stanford.edu.

Stanford University School of Medicine reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Cultural and Linguistic Competency

The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: http://lane.stanford.edu/portals/cultural.html

Conference Contact:

Debbie Aube
Meeting Planner Specialist
Ph: 650-724-5318
Email: debaube@stanford.edu